Literature DB >> 10708345

Confusion between silent and overt reading in schizophrenia.

N Franck1, P Rouby, E Daprati, J Daléry, M Marie-Cardine, N Georgieff.   

Abstract

The present study was aimed at investigating whether schizophrenic patients are impaired in monitoring their own speech. In particular, we attempted to assess their ability to discriminate between overt and covert speech in a reading task, in order to verify whether they can correctly recollect the modality in which an internally generated action is produced. Subjects were asked to read either silently or aloud, items from a list of words. After a delay of 5 min, they were required to indicate in a new list which words had been read previously (either silently or overtly), or had never been presented during the reading task. With respect to normal controls, schizophrenic patients showed a significant bias to report that they had read aloud words which they had actually read silently, or which were absent during the reading task. The results are discussed in relation to recent neuroimaging studies on inner and overt speech in hallucinating schizophrenic patients. Our data favour the hypothesis that the inability to correctly discriminate between inner and overt speech may play a role in the onset of schizophrenic hallucinations.

Entities:  

Mesh:

Year:  2000        PMID: 10708345     DOI: 10.1016/s0920-9964(99)00067-5

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  16 in total

Review 1.  A neuropsychiatric model of biological and psychological processes in the remission of delusions and auditory hallucinations.

Authors:  Mark van der Gaag
Journal:  Schizophr Bull       Date:  2006-08-11       Impact factor: 9.306

2.  Other faces in the mirror: a perspective on schizophrenia.

Authors:  Michael A Arbib
Journal:  World Psychiatry       Date:  2007-06       Impact factor: 49.548

Review 3.  Self-recognition deficits in schizophrenia patients with auditory hallucinations: a meta-analysis of the literature.

Authors:  Flavie Waters; Todd Woodward; Paul Allen; Andre Aleman; Iris Sommer
Journal:  Schizophr Bull       Date:  2010-12-08       Impact factor: 9.306

4.  Neurocognitive predictors of source monitoring in schizophrenia.

Authors:  Mohammed Kalathil Shakeel; Nancy Marsh Docherty
Journal:  Psychiatry Res       Date:  2012-07-02       Impact factor: 3.222

5.  Effects of transdermal nicotine on episodic memory in non-smokers with and without schizophrenia.

Authors:  Anthony P Weiss; A Eden Evins; Lindsay E Jubelt; Ruth S Barr; Donald C Goff; Tanya Logvinenko
Journal:  Psychopharmacology (Berl)       Date:  2008-06-12       Impact factor: 4.530

Review 6.  The perceptual characteristics of voice-hallucinations in deaf people: insights into the nature of subvocal thought and sensory feedback loops.

Authors:  Joanna R Atkinson
Journal:  Schizophr Bull       Date:  2006-03-01       Impact factor: 9.306

Review 7.  Development of rostral prefrontal cortex and cognitive and behavioural disorders.

Authors:  Iroise Dumontheil; Paul W Burgess; Sarah-Jayne Blakemore
Journal:  Dev Med Child Neurol       Date:  2008-01-11       Impact factor: 5.449

8.  Auditory verbal hallucinations result from combinatoric associations of multiple neural events.

Authors:  Massoud Stephane
Journal:  Front Hum Neurosci       Date:  2013-05-31       Impact factor: 3.169

9.  Novel evidence that attributing affectively salient signal to random noise is associated with psychosis.

Authors:  Ana Catalan; Claudia J P Simons; Sonia Bustamante; Marjan Drukker; Aranzazu Madrazo; Maider Gonzalez de Artaza; Iñigo Gorostiza; Jim van Os; Miguel A Gonzalez-Torres
Journal:  PLoS One       Date:  2014-07-14       Impact factor: 3.240

10.  External misattribution of internal thoughts and proneness to auditory hallucinations: the effect of emotional valence in the Deese-Roediger-McDermott paradigm.

Authors:  Mari Kanemoto; Tomohisa Asai; Eriko Sugimori; Yoshihiko Tanno
Journal:  Front Hum Neurosci       Date:  2013-07-09       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.